Literature DB >> 23255027

Elevated serum amyloid A is associated with venous thromboembolism.

Hiroshi Deguchi, Darlene J Elias, Silvia Navarro, Francisco España, John H Griffin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23255027      PMCID： PMC3579663          DOI： 10.1160/TH12-10-0722

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN： 0340-6245            Impact factor:   5.249


× No keyword cloud information.
  29 in total

1.  Cholesteryl ester transfer protein genotypes associated with venous thrombosis and dyslipoproteinemia in males.

Authors:  N M Pecheniuk; H Deguchi; D J Elias; X Xu; J H Griffin
Journal:  J Thromb Haemost       Date:  2006-09       Impact factor: 5.824

2.  Association of Apo(a)isoform size with dyslipoproteinemia in male venous thrombosis patients.

Authors:  Marian C Cheung; John J Albers; Hal Kennedy; Hiroshi Deguchi; Darlene J Elias; Patricia M Averell; John H Griffin; Santica M Marcovina
Journal:  Clin Chim Acta       Date:  2010-05-19       Impact factor: 3.786

3.  High-density lipoprotein deficiency and dyslipoproteinemia associated with venous thrombosis in men.

Authors:  Hiroshi Deguchi; Natalie M Pecheniuk; Darlene J Elias; Patricia M Averell; John H Griffin
Journal:  Circulation       Date:  2005-08-09       Impact factor: 29.690

4.  Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times.

Authors:  Saori Takata; Hiroo Wada; Masaki Tamura; Takashi Koide; Manabu Higaki; Shin-Ichiro Mikura; Tetsuo Yasutake; Susumu Hirao; Masuo Nakamura; Koujiro Honda; Tomoko Nagatomo; Yasutaka Tanaka; Erei Sohara; Masato Watanabe; Takuma Yokoyama; Takeshi Saraya; Daisuke Kurai; Haruyuki Ishii; Hajime Goto
Journal:  Biomarkers       Date:  2011-08-19       Impact factor: 2.658

5.  Serum amyloid A is an endogenous ligand that differentially induces IL-12 and IL-23.

Authors:  Rong He; Larry W Shepard; Jia Chen; Zhixing K Pan; Richard D Ye
Journal:  J Immunol       Date:  2006-09-15       Impact factor: 5.422

Review 6.  Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update.

Authors:  Matteo Nicola Dario Di Minno; Antonella Tufano; Walter Ageno; Paolo Prandoni; Giovanni Di Minno
Journal:  Intern Emerg Med       Date:  2011-04-02       Impact factor: 3.397

Review 7.  A role for acute-phase serum amyloid A and high-density lipoprotein in oxidative stress, endothelial dysfunction and atherosclerosis.

Authors:  Susan Hua; Changjie Song; Carolyn L Geczy; S Ben Freedman; Paul K Witting
Journal:  Redox Rep       Date:  2009       Impact factor: 4.412

8.  Contrasting effects of oral versus transdermal estrogen on serum amyloid A (SAA) and high-density lipoprotein-SAA in postmenopausal women.

Authors:  Aamer Abbas; Paul J Fadel; Zhongyun Wang; Debbie Arbique; Ishwarlal Jialal; Wanpen Vongpatanasin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-07-29       Impact factor: 8.311

9.  Serum amyloid A protein in patients with non-insulin-dependent diabetes mellitus.

Authors:  Y Kumon; T Suehiro; T Itahara; Y Ikeda; K Hashimoto
Journal:  Clin Biochem       Date:  1994-12       Impact factor: 3.281

10.  Cardiovascular risk factors and venous thromboembolism: a meta-analysis.

Authors:  Walter Ageno; Cecilia Becattini; Timothy Brighton; Rita Selby; Pieter W Kamphuisen
Journal:  Circulation       Date:  2007-12-17       Impact factor: 29.690
View more
  8 in total

Review 1.  Role of serum amyloid A in atherosclerosis.

Authors:  Preetha Shridas; Lisa R Tannock
Journal:  Curr Opin Lipidol       Date:  2019-08       Impact factor: 4.776

2.  Plasma fibrinolysis, inflammatory markers, and postthrombotic syndrome: preliminary findings from the Kids-DOTT Biobank.

Authors:  Marisol Betensky; Ernest K Amankwah; Stephanie Brandal; Allen D Everett; Neil A Goldenberg
Journal:  Blood Adv       Date:  2021-01-12

3.  Correlation study of venous thromboembolism with SAA, IL-1, and TNF-a levels and gene polymorphisms in Chinese population.

Authors:  Refukaiti Abuduhalike; Juan Sun; Li Zhao; Ailiman Mahemuti
Journal:  J Thorac Dis       Date:  2019-12       Impact factor: 2.895

4.  Serum amyloid A, protein Z, and C4b-binding protein β chain as new potential biomarkers for pulmonary tuberculosis.

Authors:  Ting-Ting Jiang; Li-Ying Shi; Li-Liang Wei; Xiang Li; Su Yang; Chong Wang; Chang-Ming Liu; Zhong-Liang Chen; Hui-Hui Tu; Zhong-Jie Li; Ji-Cheng Li
Journal:  PLoS One       Date:  2017-03-09       Impact factor: 3.240

Review 5.  High-Density Lipoproteins and Serum Amyloid A (SAA).

Authors:  Nancy R Webb
Journal:  Curr Atheroscler Rep       Date:  2021-01-15       Impact factor: 5.113

6.  Correlation Study of the Long-Term Prognosis of Venous Thromboembolism and Inflammatory Gene Polymorphisms.

Authors:  Refukaiti Abuduhalike; Juan Sun; Ailiman Mahemuti
Journal:  Int J Gen Med       Date:  2020-12-16

7.  Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.

Authors:  Hiroshi Deguchi; Silvia Navarro; Amanda B Payne; Darlene J Elias; Nicole F Dowling; Harland D Austin; Francisco España; Pilar Medina; W Craig Hooper; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2017-06-23

8.  Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients.

Authors:  José A Fernández; Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2019-12-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.